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Abstract DJ-1 is a protein involved in multiple physiological
processes, including cancer, Parkinson’s disease, and male fer-
tility. It is unknown how DJ-1 functions in the apparently di¡er-
ent systems. The crystal structure of DJ-1 at 1.6 A$ resolution
shows that DJ-1 is a helix-strand-helix sandwich and forms a
dimer. The DJ-1 structure is similar to the members of the
intracellular protease PfpI family. However, the catalytic triad
of Cys^His^Glu is not strictly conserved in DJ-1, implying that
DJ-1 has a di¡erent catalytic mechanism if it acts as a protease
or DJ-1 serves as a regulatory protein in the physiological pro-
cesses. The structure shows that Leu166 positions in the middle
of a helix and thus predicts that the L166P mutation will bend
the helix and impact the dimerization of DJ-1. As a result, the
conformational changes may diminish the DJ-1 binding with its
partner, leading to the familial Parkinson’s disease caused by
the single L166P mutation.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
DJ-1 is a ubiquitously expressed and highly conserved pro-
tein that plays important roles in several biological processes.
First, DJ-1 was reported as a novel oncogene showing a co-
operative transforming activity with H-ras [1] and encoded a
circulating tumor antigen in breast cancer [2,3]. Second, DJ-1
was reported to play an essential role in fertility. Treatment of
male rats with sperm toxicants such as ornidazole induced
infertility within 10^14 days [4^6]. The infertility was associ-
ated with the release of CAP1 (contraception-associated pro-
tein 1, a DJ-1 homolog in rat) from the spermatozoa [7^9],
depletion of SP22 (CAP1 splicing isoform) [10], or decrease of
DJ-1 level in sperm [11]. Third, DJ-1 was identi¢ed as a reg-
ulatory subunit (RS) of an RNA-binding protein complex and
inhibits the RNA-binding activity of RBP [12]. Finally, DJ-1
was implicated in Parkinson’s disease (PD). Point mutation of
Leu166 to Pro in DJ-1 protein was directly linked to an early-
onset, autosomal recessive form of familial PD [13]. The
mechanism by which DJ-1 mutation causes PD is unknown,
but oxidative stress has been implicated in the pathogenesis of
a wide variety of human diseases such as cancer and PD [13^
18]. We reported here the crystal structure of human DJ-1 and
discuss the structural implications on PD and regulation of
androgen receptor (AR).
2. Materials and methods
2.1. Subcloning, overexpression and puri¢cation of DJ-1
The gene of DJ-1 (GenBank Acc. No. AF021819) was subcloned
into vector pET3E. For ampli¢cation of the DJ-1 coding region by
polymerase chain reaction (PCR), a pair of oligonucleotide primers
was synthesized: CGACCATGGCTTCCAAAAGAGCTC for 5P-end
of the DJ-1 gene and TTCCTCGAGCTAGTCTTTAAGAACAAG-
TG for 3P-end. The NcoI and XhoI restriction sites were introduced
respectively into each primer. The ampli¢ed DJ-1 cDNA and the
expression vector pET3E were separately digested by the restriction
enzymes NcoI and XhoI, puri¢ed from agarose gel, and then ligated
by T4 DNA ligase. The plasmid pET-DJ1 was transformed into Es-
cherichia coli strain BL21(CodonPlus) for overexpression.
The E. coli cell carrying pET-DJ1 was grown in Luria^Bertani (LB)
medium at 37‡C to absorption A600 = 0.7 and then 0.1 mM isopropyl
L-D-thiogalactopyranoside (IPTG) was added for further growth at
37‡C for 5 h. The recombinant DJ-1 was fractionated by ammonium
sulfate precipitation and then puri¢ed by the chromatographic col-
umns of diethylaminoethyl (DEAE) Sepharose CL-6B (Pharmacia)
and Sephacryl S300 (Amersham-Biosciences). The puri¢ed protein
has s 95% purity as judged on basis of the sodium dodecyl sulfate
(SDS) gel and shows a single band in the native polyacrylamide gel
electrophoresis (PAGE). A typical batch of puri¢cation yielded about
50 mg DJ-1 from 2 l of cell culture.
2.2. Preparation of selenomethionyl DJ-1 (SeDJ-1)
The method outlined by Doublie [19] was used for expression of
E. coli SeDJ-1. The recombinant E. coli BL21 cell carrying the pET-
DJ1 plasmid was grown in 50 ml of LB medium at 37‡C overnight.
The cells were spun down and inoculated into 1 l of M9 minimal
medium containing 0.4% glucose, 50^100 mg/l of lysine, selenomethio-
nine, threonine, phenylalanine, leucine, isoleucine, and valine. After
the cell was grown to the mid-log phase (A600 about 0.7), the over-
expression of the SeDJ-1 was induced by 0.1 mM IPTG and the cells
were grown at 30‡C for 16 h. The SeDJ-1 protein was puri¢ed using
the same method as that for the wild-type DJ-1.
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Fig. 1. Ribbon representation of monomeric DJ-1 in two di¡erent views (a and b), and DJ-1 dimer (c and d). The red balls in c and d repre-
sent Leu166 that is located in the middle of helix H7. The purple balls are Lys130, (e) the secondary structure and sequence.
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2.3. Crystallization of DJ-1 and SeDJ-1
Crystals of DJ-1 were grown by hanging drop. The full-length DJ-1
(residues 1^189) at 8 mg/ml in a bu¡er of 20 mM Tris base (pH 7.5),
50 mM NaCl, 1 mM ethylenediamine tetraacetic acid (EDTA), and
1 mM L-mercaptoethanol (L-ME), was mixed in a 2:2 ratio with a
well bu¡er of 12% PEG3350, 0.1 M Tris base, pH 8.5, 5% MPD at
room temperature. The SeDJ-1 crystals were grown under similar
conditions as the wild type of DJ-1, except for replacement of 5%
MPD with 5% glycerol. The diamond-shaped crystals formed in a
few hours and reached a typical size of 0.3U0.3U0.3 mm in a couple
of days. The crystals have the space group of P3121 with cell dimen-
sions of a= b=75.2, c=75.3 AS .
2.4. Structure determination
Di¡raction data of the native DJ-1 and the MAD data of SeDJ-1
were collected on beamline x26c of National Synchrotron Light
Source and processed by program HKL [20]. Four selenium sites
were automatically located by the program SOLVE [21] and yielded
the ‘¢gure of merit’ of 0.81 for 16 438 re£ections at 30^2.04 AS reso-
lution. The MAD phases were improved by solvent £attening as im-
plemented in the density modi¢cation package of CCP4 [22]. The
models of the structures were built by program O [23] and re¢ned
by program CNS [24]. The statistics of the di¡raction data and struc-
ture re¢nement are shown in Table 1.
3. Results and discussion
3.1. Architecture of the structure
DJ-1 contains 189 amino acids and has a calculated molec-
ular mass of 19.8 kDa [12]. The electron density maps from
the MAD phases clearly revealed the trace of full-length DJ-1,
except for slightly weaker density for the N- and C-terminal
residues. The monomeric DJ-1 contains eight K-helices and 11
L-strands that are organized into a helix-strand-helix sand-
wich (Fig. 1). A seven-stranded sheet (B1, B2, B5^B7, and
B10, B11) forms the central core of the molecule (Fig. 1),
and is £anked by three helices (H1, H7, H8) on one side
and ¢ve helices (H2^H6) on another side. Two two-stranded
sheets (B3, B4 and B8, B9) lace the sandwich on right and left
sides. An analysis on the backbone conformation showed that
most residues in the DJ-1 structure have the energy-favored
conformations, except for Cys106 that has the energy-disal-
lowed backbone conformation of B=66‡ and i=3106‡. This
unusual conformation was veri¢ed by the omitted maps and
may be compensated by two hydrogen bonds between the
backbone nitrogen of Cys106 and carbonyl oxygen of
Ser155 and between carbonyl oxygen of Cys106 and the back-
bone nitrogen of His126.
Although the crystallographic asymmetric unit contains one
molecule, DJ-1 is tightly associated into a dimer in the crys-
tals. The dimeric interface is formed between helices H1, H7,
H8 and strands B3 and B4 (Fig. 1). It contains eight pairs of
hydrogen bonds (Glu15 OO1^Asp24 ON2, Glu15 OO1^Arg28
NH2, Arg27 NH1^Arg48 O, Val51 O^Cys53 N, His126 NO2^
Pro184 O, Arg145 NH1^Val186 O, Arg145 NH2^Val186 O,
Fig. 2. Superposition of DJ-1 (golden) over intracellular protease PH1704 (cyan, left) and E. coli heat shock protein HSP31 (green, right).
Table 1
Statistics on the di¡raction data and structure of DJ-1
Crystals Wavelength (AS ) Unit cell (a, c) Resolution (AS ) Re£ections Rmergea I/ca Completenessa (%)
Total Unique
SeDJ-1 0.9800 75.53, 75.52 2.0 326 808 16 349 0.070(0.173) 23.0(25.0) 95.2(51.2)
SeDJ-1 0.9791 75.53, 75.50 2.0 320 822 16 363 0.078(0.149) 27.2(32.8) 95.6(54.9)
SeDJ-1 0.9611 75.50, 75.52 2.0 268 318 17 204 0.080(0.238) 17.9(15.8) 100.0(100.0)
Native 0.9790 75.23, 75.31 1.6 337 226 33 002 0.071(0.525) 12.4(5.0) 100.0(100.0)
Figure of merit from SOLVE: 0.81 for 16 438 re£ections at 30^2.04 AS resolution. Structure re¢nement: R-factor/R-free: 0.191/0.202; resolution:
1.6 AS ; number of re£ections: 31 910 (3179); root mean square deviation for bonds and angles: 0.004 and 1.33‡; average B-factors (AS 2): 16.0
for 1391 protein atoms, 27.9 for 195 water molecules.
aThe numbers in the parentheses are for the highest resolution shell, 2.00^2.07 AS for SeDJ-1 and 1.60^1.66 AS for the native DJ-1. Space group
is P3121.
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and Gly159 N^Leu185 O) and numerous van der Waal’s in-
teractions.
3.2. A putative binding pocket in DJ-1
We used bioinformatic tools to explore the possible roles of
DJ-1 in the biological systems. The structure comparison by
program DALI [25] revealed that 355 structures in Protein
Data Bank have Z-scores s 2, presumably having a certain
degree of structural similarity to DJ-1. The best comparable
structure is an intracellular protease PH1704 from Pyrococus
horikoshii [27], as predicted on basis of the sequence alignment
[13]. In addition, the recently determined structure of E. coli
heat shock protein Hsp31 [26] also has high degree of struc-
tural similarity with DJ-1. The superposition showed the root
mean square deviations of 1.73 AS for the backbone atoms of
160 residues between DJ-1 and PH1704, and 1.46 AS for the
backbone atoms of 120 residues between DJ-1 and hsp31 (Fig.
2). On the other hand, the sequence alignment by program
BLAST [28] showed that DJ-1 has signi¢cant sequence iden-
tity with the PfpI protease family (PH1704, PfpI, ThiJ), a
catalase, and an enzyme involved in thiamine (4-methyl-5(B-
hydroxyethyl)-thiazol monophosphate) biosynthesis.
On basis of the sequence and structure similarity, we care-
fully examined the possibility that DJ-1 serves as a protease in
the biological processes. In the structure of protease PH1704,
the ‘catalytic triad’ of Cys^His^Glu is located in the active site
(Fig. 3) that is jointly formed between two neighboring sub-
units in the PH1704 hexamer [27]. The catalytic triad is the
key catalytic element in various classes of enzymes, including
proteases [29], hydrolases [30], transglutaminases [31], and
amidotransferases [32]. DJ-1 contains a pocket with similar
shape and size as the active site of PH1704, which is made
up of residues Glu18, Lys32, Arg48, Asn76, Cys100, Thr110,
and His126 from the same subunit and also residues Arg28
and Leu185 from the neighboring subunit of the DJ-1 dimer
(Figs. 1 and 3). We speculate that this pocket serves as a
binding site for protein substrates. However, the ‘catalytic
triad’ is not strictly conserved in DJ-1. The structure compar-
ison showed that Cys106 of DJ-1 has an energy-disallowed
con¢guration, the same as Cys100 of PH1704, but the neigh-
boring histidine is replaced with Ala107. To search a possible
replacement of the histidine, we examined the structure in a
graphic system and found His126 within 5 AS to Cys106. How-
ever, no glutamate or aspartate within the same monomer or
from the molecules related by crystallographic symmetry is
found to form hydrogen bonds with His126. Thus, the struc-
tural comparison suggests that DJ-1 does not function as a
PH1704-like protease. However, one could not rule out the
possibility that DJ-1 may use a di¡erent catalytic mechanism,
e.g. the Cys^His diad, to carry out protease function.
3.3. Implication of the L166P mutation and PD
A single mutation of Leu166 to proline of DJ-1 has been
reported to cause neurodegeneration and PD [13]. In trans-
fected COS cells, V5-His-tagged wild-type DJ-1 exhibited a
di¡use cytoplasmic and nuclear staining pattern, whereas
V5-His-tagged L166P mutant DJ-1, although showing similar
nuclear staining, was mostly localized to mitochondria [13].
The crystal structure of DJ-1 provides clues to how the L166P
mutation causes DJ-1 to mislocalize to mitochondria. Leu166
is positioned in the middle of helix H7 in the DJ-1 structure
Fig. 3. The catalytic triad of Cys100^His101 and Glu74 at the active site of PH1704 (left). The dotted lines represent the hydrogen bonds. Res-
idue Glu74 comes from the neighboring subunit in the hexamer of PH1704. Right, a putative binding pocket of DJ-1. The catalytic triad is not
conserved in DJ-1, but the pocket may still be capable of binding with its substrate proteins.
Fig. 4. The interfacial region of DJ-1 dimer and the position of
Leu166. Two helices H7 and H8 are shown in the similar orienta-
tion as in Fig. 1d. The L166P mutation is expected to cause signi¢-
cant conformational changes and to impact the dimerization of
DJ-1.
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and forms, together with the residues from helices H7 and H8,
a local hydrophobic core of the dimer interface (Fig. 4). Since
Leu166 is not exposed to the surface of the DJ-1 dimer, it is
unlikely that Leu166 directly interacts with binding partners.
In crystal structures, a proline positioning in middle of a helix
will cause kink or 20^30‡ bend of the helix axis [33]. Thus, the
L166P mutation of DJ-1 is expected to change signi¢cantly
the conformations on the region around H7 and potential
reorientation of helix H8 due to the H7 bend. Since both
helices H7 and H8 are key elements in formation of the
DJ-1 dimer, the L166P mutation must also cause changes of
dimerization or quaternary structure. As a result, the confor-
mational changes may cause the mislocalization of DJ-1 to
mitochondria or diminish interactions of DJ-1 with the bind-
ing partners, thus leading to development of PD.
3.4. DJ-1 and its potential regulation on AR
Two proteins in testis were reported to bind DJ-1: DJBP
(DJ-1-binding protein) and PIASxK (protein inhibitor of acti-
vated STAT). Both DJBP and PIASxK bind to the DNA-
binding domain of AR and inhibit in a testosterone-dependent
manner the transcription activity of AR [34,35]. DJBP has 570
amino acids and contains three calmodulin-like domains as
predicted by BLAST [28], but its exact function is unknown.
PIAS is a family of proteins known as SUMO-1 (small ubiq-
uitin-related modi¢er 1) ligases and regulates various tran-
scription factors such as p53 and steroid hormone receptors
[36,37]. DJ-1 is sumoylated at Lys130 by a SUMO ligase,
presumably by PIAS [35]. The wild type of DJ-1 reverses
the inhibition by binding to PIASxK [35]. However, the single
K130R mutation or the quartic mutation (K130R, S57R,
E96G, and H126Y) failed to bind PIASxK so as to be unable
to reverse the inhibition of PIASxK on AR. The crystal struc-
ture showed that Lys130 is located on the surface of the DJ-1
molecule (Fig. 1). This residue is spatially available for su-
moylation. However, it is not clear whether the loss of binding
capacity of PIASxK is due to sumoylation or the amino acid
replacement. On the other hand, residues Ser57, Glu96, and
His126 are located at distal places of the DJ-1 surface and do
not seem to structurally correlate with one another. Since the
single mutation of K130R has a similar e¡ect as the quartic
mutation, the other residues might play a less critical role in
the binding of PIASxK.
While DJ-1 has been shown to play important roles in
cancer, PD, and male fertility, how DJ-1 functions in the
diverse physiological processes is unknown. The crystal struc-
ture of DJ-1 shows that the catalytic triad is not conserved in
DJ-1, implying that DJ-1 has a di¡erent mechanism if it acts
as a protease. Most likely, DJ-1 serves as a regulatory protein
in the various physiological processes, presumably via inter-
actions with its binding partners such as BJBP and PIAS. The
crystal structures of DJ-1 in complex with its partners will
ultimately reveal the regulation mechanism in the multiple
physiological processes.
4. Note added in proof
During the submission of our manuscript, the structure of
DJ-1 was electronically published online of J. Biol. Chem. by
two groups (Tao, X. and Tong, L. (2003) Crystal structure of
human DJ-1, a protein associated with early-onset Parkin-
son’s disease, J. Biol. Chem. May; Honbou, K., Suzuki,
N.N., Horiuchi, M., Niki, T., Taira, T., Ariga, H. and Inaga-
ki, F. (2003) The crystal structure of DJ-1, a protein related to
male fertility and Parkinson’s disease, J. Biol. Chem., June).
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